Literature DB >> 3199818

Human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase: purification from microsomes, substrate kinetics, and inhibition by product steroids.

J L Thomas1, E A Berko, A Faustino, R P Myers, R C Strickler.   

Abstract

In human pregnancy, placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase produce progesterone from pregnenolone and metabolize fetal dehydroepiandrosterone sulfate to androstenedione, an estrogen precursor. The enzyme complex was solubilized from human placental microsomes using the anionic detergent, sodium cholate. Purification (500-fold, 3.9% yield) was achieved by ion exchange chromatography (Fractogel-TSK DEAE 650-S) followed by hydroxylapatite chromatography (Bio-Gel HT). The purified enzyme was detected as a single protein band in sodium dodecylsulfate-polyacrylamide gel electrophoresis (monomeric Mr = 19,000). Fractionation by gel filtration chromatography at constant specific enzyme activity supported enzyme homogeneity and determined the molecular mass (Mr = 76,000). The dehydrogenase and isomerase activities copurified. Kinetic constants were determined at pH 7.4, 37 degrees C for the oxidation of pregnenolone (Km = 1.9 microM, Vmax = 32.6 nmol/min/mg) and dehydroepiandrosterone (Km = 2.8 microM, Vmax = 32.0 nmol/min/mg) and for the isomerization of 5-pregnene-3,20-dione (Km = 9.7 microM, Vmax = 618.3 nmol/min/mg) and 5-androstene-3,17-dione (Km = 23.7 microM, Vmax = 625.7 nmol/min/mg). Mixed substrate analyses showed that the dehydrogenase and isomerase reactions use the appropriate pregnene and androstene steroids as alternative, competitive substrates. Dixon analyses demonstrated competitive inhibition of the oxidation of pregnenolone and dehydroepiandrosterone by both product steroids, progesterone and androstenedione. The enzyme has a 3-fold higher affinity for androstenedione than for progesterone as an inhibitor of dehydrogenase activity. Based on these competitive patterns of substrate utilization and product inhibition, the pregnene and androstene activities of 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase may be expressed at a single catalytic site on one protein in human placenta.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3199818     DOI: 10.1016/0022-4731(88)90287-7

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  11 in total

1.  Regional chromosomal assignment of human 3-beta-hydroxy-5-ene steroid dehydrogenase to 1p13.1 by non-isotopic in situ hybridisation.

Authors:  N Morrison; D A Nickson; M W McBride; U W Mueller; E Boyd; R G Sutcliffe
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

Review 2.  Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.

Authors:  Lina Schiffer; Lise Barnard; Elizabeth S Baranowski; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Cedric H L Shackleton; Karl-Heinz Storbeck
Journal:  J Steroid Biochem Mol Biol       Date:  2019-07-27       Impact factor: 4.292

3.  Immunolocalization of 3β-hydroxysteroid dehydrogenase in human adrenal cortex and in its disorders.

Authors:  Hironobu Sasano; J Lan Mason; Nobuaki Sasano; Hiroshi Nagura
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

Review 4.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

5.  Identification of key amino acids responsible for the substantially higher affinities of human type 1 3beta-hydroxysteroid dehydrogenase/isomerase (3beta-HSD1) for substrates, coenzymes, and inhibitors relative to human 3beta-HSD2.

Authors:  James L Thomas; Elizabeth L Boswell; Launa A Scaccia; Vladimir Pletnev; Timothy C Umland
Journal:  J Biol Chem       Date:  2005-03-28       Impact factor: 5.157

6.  Rational proteomics V: structure-based mutagenesis has revealed key residues responsible for substrate recognition and catalysis by the dehydrogenase and isomerase activities in human 3beta-hydroxysteroid dehydrogenase/isomerase type 1.

Authors:  Vladimir Z Pletnev; James L Thomas; Felicia L Rhaney; Lynley S Holt; Launa A Scaccia; Timothy C Umland; William L Duax
Journal:  J Steroid Biochem Mol Biol       Date:  2006-08-04       Impact factor: 4.292

7.  The functions of key residues in the inhibitor, substrate and cofactor sites of human 3beta-hydroxysteroid dehydrogenase type 1 are validated by mutagenesis.

Authors:  James L Thomas; Vance L Mack; Jingping Sun; J Ross Terrell; Kevin M Bucholtz
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-24       Impact factor: 4.292

8.  Multiple forms of mouse 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase and differential expression in gonads, adrenal glands, liver, and kidneys of both sexes.

Authors:  P A Bain; M Yoo; T Clarke; S H Hammond; A H Payne
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

9.  Structure/function of the inhibition of human 3beta-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane.

Authors:  James L Thomas; Vance L Mack; Jason A Glow; Delaram Moshkelani; J Ross Terrell; Kevin M Bucholtz
Journal:  J Steroid Biochem Mol Biol       Date:  2008-05-03       Impact factor: 4.292

10.  Structure/function of human type 1 3beta-hydroxysteroid dehydrogenase: An intrasubunit disulfide bond in the Rossmann-fold domain and a Cys residue in the active site are critical for substrate and coenzyme utilization.

Authors:  James L Thomas; Robert Huether; Vance L Mack; Launa A Scaccia; Ryan C Stoner; William L Duax
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-25       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.